Wysocki, Jacek
Malecka, Ilona
Stryczynska-Kazubska, Joanna
Rampakakis, Emmanouil
Kuter, Barbara
Wolfson, Lara J.
Funding for this research was provided by:
Merck
Article History
Received: 20 July 2017
Accepted: 12 March 2018
First Online: 27 March 2018
Ethics approval and consent to participate
: In line with the local regulations, notification to the central Ethics Committee of the Central Register of Clinical Trials in the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products was done for all participating sites. Patient consent was not required, as data were collected retrospectively and provided by the treating physicians in an anonymous manner, identified only by an encrypted patient number.
: Not applicable.
: Jacek Wysocki: paid lecturer for Pfizer and Sanofi, investigator in clinical trials by GSK, Pfizer, Sanofi Pasteur, Actelion and MSD.Ilona Malecka: Paid lecturer for MSD, Sanofi-Aventis.Joanna Stryczynska-Kazubska: Paid lecturer for MSD, Sanofi, Pasteur.Emmanouil Rampakakis: Employee at JSS Medical Research, the CRO hired.Barbara Kuter: Employee and stock shareholder of Merck & Co., Inc.Lara J. Wolfson: Employee and stock shareholder of Merck & Co., Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.